Oncotarget

Research Papers:

Docosahexaenoic acid and disulfiram act in concert to kill cancer cells: a mutual enhancement of their anticancer actions

Yang Jiao, Bethany N. Hannafon, Roy R. Zhang, Kar-Ming Fung and Wei-Qun Ding _

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:17908-17920. https://doi.org/10.18632/oncotarget.14702

Metrics: PDF 1241 views  |   HTML 1730 views  |   ?  


Abstract

Yang Jiao1,2, Bethany N. Hannafon1, Roy R. Zhang1, Kar-Ming Fung1,3, Wei-Qun Ding1,3

1Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA

2School of Radiation Medicine and Protection, Medical College of Soochow University, Suzhou 215123, P.R. China

3Peggy and Charles Stephenson Cancer Center, Oklahoma City, OK 73104, USA

Correspondence to:

Wei-Qun Ding, email: weiqun-ding@ouhsc.edu

Keywords: docosahexaenoic acid, disulfiram, oxidative stress, nuclear factor (erythroid-derived 2)-like 2, cancer stem cell

Received: June 17, 2016    Accepted: December 16, 2016    Published: January 17, 2017

ABSTRACT

We previously reported a synergistic anticancer action of clioquinol and docosahexaenoic acid (DHA) in human cancer cells. However, clioquinol has been banned from the clinic due to its neurotoxicity. This study identified disulfiram (DSF) as a substitute compound to clioquinol, acting in concert with DHA to more effectively kill cancer cells and suppress tumor growth. Treatment with DSF and DHA induced greater apoptotic cell death and suppression of tumor growth in vitro and in vivo, as compared to DSF and DHA used alone. Mechanistic studies demonstrated that DSF enhances DHA-induced cellular oxidative stress as evidenced by up-regulation of Nrf2-mediated heme oxygenase 1 (HO-1) gene transcription. On the other hand, DHA was found to enhance DSF-induced suppression of mammosphere formation and stem cell frequency in a selected cancer model system, indicating that alterations to cancer cell stemness are involved in the combinatory anticancer action of DSF and DHA. Thus, DHA and DSF, both clinically approved drugs, act in concert to more effectively kill cancer cells. This combinatory action involves an enhancement of cellular oxidative stress and suppression of cancer cell stemness.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 14702